CN111671025B - Sugar electrolyte beverage for relieving alcoholism and preparation method thereof - Google Patents
Sugar electrolyte beverage for relieving alcoholism and preparation method thereof Download PDFInfo
- Publication number
- CN111671025B CN111671025B CN202010604148.1A CN202010604148A CN111671025B CN 111671025 B CN111671025 B CN 111671025B CN 202010604148 A CN202010604148 A CN 202010604148A CN 111671025 B CN111671025 B CN 111671025B
- Authority
- CN
- China
- Prior art keywords
- icodextrin
- edible
- beverage
- glucose
- potassium chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 46
- 239000003792 electrolyte Substances 0.000 title claims abstract description 27
- 235000000346 sugar Nutrition 0.000 title claims abstract description 20
- 208000007848 Alcoholism Diseases 0.000 title claims abstract description 15
- 201000007930 alcohol dependence Diseases 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title abstract description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 81
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 68
- 229920002177 Icodextrin Polymers 0.000 claims abstract description 55
- 229940016836 icodextrin Drugs 0.000 claims abstract description 55
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 39
- 239000008103 glucose Substances 0.000 claims abstract description 39
- 150000003839 salts Chemical class 0.000 claims abstract description 37
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 34
- 239000001103 potassium chloride Substances 0.000 claims abstract description 34
- 239000002994 raw material Substances 0.000 claims abstract description 30
- 239000003651 drinking water Substances 0.000 claims abstract description 28
- 235000020188 drinking water Nutrition 0.000 claims abstract description 28
- 239000000463 material Substances 0.000 claims abstract description 21
- 206010019133 Hangover Diseases 0.000 claims abstract description 11
- 235000002639 sodium chloride Nutrition 0.000 claims description 32
- 238000004806 packaging method and process Methods 0.000 claims description 12
- 235000015165 citric acid Nutrition 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 19
- 210000004185 liver Anatomy 0.000 abstract description 11
- 150000001720 carbohydrates Chemical class 0.000 abstract description 6
- 235000014633 carbohydrates Nutrition 0.000 abstract description 6
- 230000035622 drinking Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 235000013373 food additive Nutrition 0.000 abstract description 4
- 239000002778 food additive Substances 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 230000002075 anti-alcohol Effects 0.000 abstract description 2
- 241000699670 Mus sp. Species 0.000 description 21
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 17
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 17
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000006872 improvement Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000035987 intoxication Effects 0.000 description 3
- 231100000566 intoxication Toxicity 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 108010025188 Alcohol oxidase Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention provides a sugar electrolyte beverage for relieving alcoholism and a preparation method thereof, and the sugar electrolyte beverage is characterized in that: the main raw materials comprise icodextrin, edible glucose and edible salt, and the ratio of the main raw materials is as follows: 0.1-35g/L of icodextrin, 30-120g/L of glucose and 1-10g/L of edible salt; the auxiliary materials at least comprise a proper amount of potassium chloride, a proper amount of citric acid and the balance of drinking water. The icodextrin is used as the food additive of the anti-alcohol beverage and is reasonably matched with other raw materials, so that the endurance and the working capacity of the organism can be rapidly increased, the effects of relieving discomfort after drinking and preventing alcohol and liver are achieved, and the beverage has good taste and good quality stability. The invention also provides a preparation method of the carbohydrate electrolyte beverage for alleviating hangover, and the preparation method has a reasonable process.
Description
Technical Field
The invention belongs to the technical field of beverage products and processing and preparation processes thereof, and particularly relates to a sugar electrolyte beverage for alleviating hangover and a preparation method thereof.
Background
With the improvement of living standard of people and frequent commercial and social activities, excessive drinking is a problem which is often encountered by people and causes great harm to liver, spleen and stomach, central nerve and the like of people. Ethanol is absorbed by gastrointestinal tract after entering into body, only 2% -10% is discharged in original form from respiratory tract, urine and sweat gland, and the rest 98% -90% is oxidized in liver (rarely metabolized extrahepatic); about 80% of the ethanol metabolized by the liver is converted into acetaldehyde by Alcohol Dehydrogenase (ADH), about 20% of the ethanol is converted into acetaldehyde by microsomal alcohol oxidase, and the acetaldehyde is converted into acetic acid by acetaldehyde dehydrogenase (ALDH), enters tricarboxylic acid cycle, and is oxidized into carbon dioxide and water. The generation of acetaldehyde can stimulate the secretion of adrenal hormone, norepinephrine and the like, thereby causing the symptoms of red-ear, accelerated heart rate, high skin temperature and the like. Alcohol can inhibit the production of antidiuretic hormone, resulting in increased urine, and water in wine increases urine source. The water and electrolyte in the human body can be lost to a corresponding degree while the human body urinates.
Whether hepatic or mitochondrial, energy supply is required. The existing sobering-up products on the market have uneven quality and curative effect, and have non-lasting energy supply or unclear mechanism. Glucose and the like can cause rapid rise of blood sugar and blood pressure as energy supply, and glucan such as modified starch, resistant dextrin, fructo-oligosaccharide and the like can be used as a continuous energy supply raw material, but the structure is uncertain, and the quality stability cannot be ensured.
Icodextrin is a glucan which is prepared by hydrolyzing and refining starch, is connected by alpha (1-4) and less than 10 percent of alpha (1-6) glycosidic bonds, has an average molecular weight of 25000-34000 daltons, has good water solubility, safety and biocompatibility, and has the characteristics of low sweetness, low heat and low osmotic pressure. It cannot participate in non-enzymatic glycosylation reaction, and the final product of the metabolism is maltodextrin, which is difficult to participate in glycosylation reaction. The absorptivity of the peritoneum to the icodextrin is 1/4 of glucose in the same time, namely the absorptivity of human body to the icodextrin is low; but can be continuously hydrolyzed in intestinal tracts, and has the effects of prolonging energy supply of human bodies and strengthening body endurance and working capacity.
At present, icodextrin is mainly used for medical products such as peritoneal dialysis solution, however, a technical disclosure of using icodextrin in an anti-hangover beverage has not been made so far.
How to develop a sugar electrolyte beverage for relieving alcoholism and a preparation method thereof, which utilize icodextrin as a food additive of the beverage for relieving alcoholism, reasonably match with other raw materials, play the role of relieving alcoholism and research a proper preparation method, is a technical problem to be urgently solved in the field.
Disclosure of Invention
In order to solve the problems in the background art, the invention provides the carbohydrate electrolyte beverage for relieving alcoholism, which utilizes the icodextrin as the food additive of the beverage for relieving alcoholism, is reasonably matched with other raw materials, can rapidly increase the endurance and the work capacity of the organism, has the effects of relieving discomfort after drinking and relieving alcoholism and protecting liver, and has good taste and good quality stability; the invention also provides a preparation method of the carbohydrate electrolyte beverage for alleviating hangover, and the preparation method has a reasonable process.
In order to achieve the purpose, the invention provides the following technical scheme: the sugar electrolyte beverage for relieving alcoholism is characterized in that the main raw materials comprise icodextrin, edible glucose and edible salt, and the ratio of the main raw materials is as follows: 0.1-35g/L of icodextrin, 30-120g/L of glucose and 1-10g/L of edible salt; the auxiliary materials at least comprise a proper amount of potassium chloride, a proper amount of citric acid and the balance of drinking water.
The improvement of the technical scheme is as follows: the main raw materials are as follows: 4-10g/L of icodextrin, 40-100g/L of edible glucose and 4-9g/L of edible salt; the auxiliary materials at least comprise 0.2-1g/L of potassium chloride, a proper amount of citric acid and the balance of drinking water.
The first improvement of the technical scheme is as follows: the main raw materials are as follows: 7.5 g/L of icodextrin, 40g/L of glucose and 9g/L of edible salt; the auxiliary materials comprise 0.2g/L of potassium chloride, a proper amount of citric acid and the balance of water.
The second improvement of the technical scheme is as follows: the main raw materials are as follows: 4 g/L of icodextrin, 100g/L of glucose and 9g/L of edible salt; the auxiliary materials comprise 1g/L of potassium chloride, a proper amount of citric acid and the balance of water.
The third improvement on the technical scheme is as follows: the main raw materials are as follows: 10g/L of icodextrin, 45g/L of glucose and 4.5g/L of edible salt; the auxiliary materials comprise 0.2g/L of potassium chloride, a proper amount of citric acid and the balance of water.
The invention relates to a preparation method of the sugar electrolyte beverage for relieving alcoholism, which is characterized by comprising the following steps of:
(1) preparing according to the mixture ratio of the raw materials: icodextrin, glucose, edible salt, potassium chloride, citric acid and drinking water;
(2) adding 60-80 ℃ and 60-85% of full batch volume of drinking water into a container;
(3) then adding icodextrin, edible glucose, edible salt and potassium chloride in sequence, and stirring until the icodextrin, the edible glucose, the edible salt and the potassium chloride are fully dissolved;
(4) adding drinking water to full volume and constant volume, and adjusting pH value to be less than or equal to 7.5 by using citric acid;
(5) UHT sterilizing, packaging, sealing, and packaging.
Compared with the prior art, the invention has the following advantages and positive effects:
1. the invention uses the icodextrin as the food additive of the beverage for alleviating hangover, and the icodextrin is reasonable with other raw materials
In combination, the icodextrin is used as a novel functional food raw material with a definite structure, can maintain the blood sugar level of a human body when needing energy, avoids blood concentration and the generation of a large amount of lactic acid in blood, quickly increases the endurance and the work capacity of the body and improves the working efficiency; the symptoms of night sweat, dehydration and the like after a large amount of physical strength consumption and long-time strenuous exercise of a human body are overcome. Has good effect on a series of physiological changes such as blood sugar reduction, body temperature rise, brain dysfunction and the like caused by excessive consumption of energy resources, and can effectively improve the drunkenness symptom.
2. The invention adopts the icodextrin as a slow-release energy source, and can continuously supply energy in the alcohol decomposition process after being taken, thereby reducing the damage of alcohol to the liver and the body.
3. The icodextrin adopted by the invention has low sweetness, good taste and good moisture retention, is not easy to crystallize, and can effectively improve the flavor of the beverage.
Detailed description of the invention
The invention relates to a specific implementation mode of a carbohydrate electrolyte beverage for relieving alcoholism, which comprises main raw materials including icodextrin, edible glucose and edible salt, wherein the main raw materials comprise the following components in percentage by weight: 0.1-35g/L of icodextrin, 30-120g/L of glucose and 1-10g/L of edible salt; the auxiliary materials at least comprise a proper amount of potassium chloride, a proper amount of citric acid and the balance of water.
The specific implementation mode of the preparation method of the carbohydrate electrolyte beverage for relieving alcoholism comprises the following steps:
(1) preparing according to the mixture ratio of the raw materials: icodextrin, glucose, edible salt, potassium chloride, citric acid and drinking water;
(2) adding 60-80 ℃ and 60-85% of full batch volume of drinking water into a container;
(3) then adding icodextrin, edible glucose, edible salt and potassium chloride in sequence, and stirring until the icodextrin, the edible glucose, the edible salt and the potassium chloride are fully dissolved;
(4) adding drinking water to full volume and constant volume, and adjusting pH value to be less than or equal to 7.5 by using citric acid;
(5) UHT sterilizing, packaging, sealing, and packaging.
The present invention will be described in further detail with reference to specific examples below:
example 1:
an alcohol-relieving electrolyte beverage I containing icodextrin comprises the following raw materials in proportion: 7.5 g/L of icodextrin, 40g/L of glucose, 9g/L of edible salt and auxiliary materials; the auxiliary materials comprise 0.2g/L of potassium chloride, a proper amount of citric acid and the balance of drinking water, and the beverage with the pH value of 4.0 is prepared.
The preparation method comprises the following steps: (1) preparing according to the mixture ratio of the raw materials: icodextrin, glucose, edible salt, potassium chloride, citric acid and drinking water;
(2) adding 60-80 ℃ and 60-85% of full batch volume of drinking water into a container;
(3) then adding icodextrin, edible glucose, edible salt and potassium chloride in sequence, and stirring until the icodextrin, the edible glucose, the edible salt and the potassium chloride are fully dissolved;
(4) adding drinking water to full volume and constant volume, and adjusting pH value to 4.0 with citric acid;
(5) UHT sterilizing, packaging, sealing, and packaging.
Example 2:
an alcohol-relieving electrolyte beverage II containing icodextrin comprises the following raw materials in proportion: 4 g/L of icodextrin, 100g/L of glucose, 9g/L of edible salt and auxiliary materials; the auxiliary materials comprise 1g/L of potassium chloride, a proper amount of citric acid and the balance of drinking water, and the beverage with the pH value of 4.0 is prepared.
The preparation method comprises the following steps: (1) preparing according to the mixture ratio of the raw materials: icodextrin, glucose, edible salt, potassium chloride, citric acid and drinking water;
(2) adding 60-80 ℃ and 60-85% of full batch volume of drinking water into a container;
(3) then adding icodextrin, edible glucose, edible salt and potassium chloride in sequence, and stirring until the icodextrin, the edible glucose, the edible salt and the potassium chloride are fully dissolved;
(4) adding drinking water to full volume and constant volume, and adjusting pH value to 4.0 with citric acid;
(5) UHT sterilizing, packaging, sealing, and packaging.
Example 3:
an alcohol-relieving electrolyte beverage III containing icodextrin comprises the following raw materials in proportion: 10g/L of icodextrin, 45g/L of glucose, 4.5g/L of edible salt and auxiliary materials; the auxiliary materials comprise 0.2g/L of potassium chloride, a proper amount of citric acid and the balance of drinking water, and the beverage with the pH value of 4.0 is prepared.
The preparation method comprises the following steps: (1) preparing according to the mixture ratio of the raw materials: icodextrin, glucose, edible salt, potassium chloride, citric acid and drinking water;
(2) adding 60-80 ℃ and 60-85% of full batch volume of drinking water into a container;
(3) then adding icodextrin, edible glucose, edible salt and potassium chloride in sequence, and stirring until the icodextrin, the edible glucose, the edible salt and the potassium chloride are fully dissolved;
(4) adding drinking water to full volume and constant volume, and adjusting pH value to 4.0 with citric acid;
(5) UHT sterilizing, packaging, sealing, and packaging.
The following are tests on the use effect of the sugar electrolyte beverage for alleviating hangover of the present invention:
test one: a young female, 26 years old, needs to drink alcohol for compensation during work, has obvious symptoms of dizziness and nausea after drinking, and generally needs 6-10 hours to wake up. When the type III beverage of the invention is taken by 250ml 30min before drinking, the wine capacity is increased by 1 time, no obvious drunk phenomenon occurs, only the blush condition occurs, and the blush phenomenon completely disappears after 2 hours. The phenomenon of serious drunkenness appears when the beverage is not taken before one time, and the phenomenon of drunkenness disappears after the beverage is taken 30min after drinking the type III beverage of the invention and 250ml after 4 hours.
And (2) test II:
1. apparatus and materials
1.1 Experimental animals
Healthy male NIH mice with a body weight of 20g + -2 g
1.2 materials
1.2.1 reagents
56 degree Chinese liquor, Alcohol Dehydrogenase (ADH), alcohol-relieving electrolyte beverage III containing icodextrin, control sugar saline beverage, normal saline, ADH kit, and ALT kit
The formula of the sugar saline beverage of the control group 1 comprises the following components: 50g/L of glucose, 4.5g/L of edible salt and auxiliary materials; the auxiliary materials comprise 0.2g/L of potassium chloride, a proper amount of citric acid and the balance of water, and the beverage with the pH value of 4.0 is prepared.
Control 2 group was Haiwang Jinzun anti-hangover oral liquid.
1.2.2 instruments
Gas chromatograph and electronic balance
2. Method of producing a composite material
2.1 alcohol resistance test in mice
60 mice were taken and randomly divided into six groups of 10 mice each. Fasting was overnight (12 h) prior to the experiment. The blank group and the model group were both administered with physiological saline at a dose of 0.1ml/10g, and the control group 1 and the control group 2 were administered with sugar saline beverage at a dose of 0.1ml/10 g. The experimental low-dose group, the medium-dose group and the high-dose group are respectively filled with the product according to 0.05ml/10g body weight, 0.1ml/10g body weight and 0.2ml/10g body weight to relieve alcoholism and take the type III electrolyte beverage; after 30min, each mouse in the blank group was administered with distilled water at a concentration of 0.15ml/10g, and the other mice were administered with 56% (v/v) Chinese liquor at a concentration of 0.15ml/10 g. The activity of the mice was observed, the climbing time, the drunk rate and the drunk time of the mice were recorded, and the number of deaths of each group of mice within 24 hours was recorded.
2.2 serum alcohol concentration and Alcoholic liver and stomach injury test
50 male NIH mice (weighing 18-22 g) were divided into five groups of 10 mice and fasted overnight (12 h) prior to the experiment. In the morning, the blank group and the model group are filled with normal saline only at 0.1ml/10g of body weight, the control 1 group is filled with saline beverage at 0.1ml/10g of body weight, and the control 2 group is filled with Haiwang Jinzun oral liquid at 0.1ml/10g of body weight. The experimental group takes the product to fill and take the type III antialcoholism electrolyte beverage containing the icodextrin according to the weight of 0.1ml/10 g. After 30min, each mouse in the blank group was administered with distilled water at a concentration of 0.1ml/10g, and the other mice were administered with 56% (v/v) Chinese liquor at a concentration of 0.1ml/10 g. Continuously drenching for 7 days, drenching for 30min as usual on 7 days, immediately killing after blood is taken from eye sockets, taking out the liver of the mouse, removing the envelope of the liver, repeatedly washing the stomach with precooled normal saline after contents are removed, sucking dry with filter paper, weighing, and performing 1: 10 adding pre-cooled 1.15% potassium chloride solution to homogenize liver separately, and measuring the activity of Alcohol Dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALD) in liver tissue. ADH, ALH activity is expressed as moles produced per g of tissue per min. If dead mice are removed in the experimental process, no test is carried out.
3. Results
3.1 mouse alcohol resistance test results (see Table 1)
TABLE 1 mice intoxicated and mortality
| Group of | Intoxication rate/%) | Drunk time/min | Sobering-up time/min | Mortality rate/%) |
| Blank group | 0 | 0 | 0 | 0 |
| Model set | 100 | 8.4±2.7 | 400.2±50.4 | 4 |
| Control 1 group | 70 | 13.1±1.5 | 320.5±45.3 | 0 |
| Control 2 group | 60 | 15.0±2.0 | 270.5±70.4 | 0 |
| Test Low dose group | 70 | 13.6±2.5 | 315.2±60.9 | 0 |
| Dose group in test | 50 | 15.2±1.1 | 250.5±50.0 | 0 |
| Test high dose group | 30 | 16.7±2.5 | 200.2±49.5 | 0 |
Note: the positive and negative reflexes of the mice disappear, the mice are proved to be drunk, and the drunk rate refers to the ratio of the number of drunk mice to the number of mice in the group; the drunk time refers to the time from the drunk mouse to be drenched with white spirit until the positive and negative reflections disappear; the time to sober-up refers to the time from disappearance of positive and negative reflections to re-recovery, expressed as mean ± sd.
As can be seen from Table 1, the control 1 group, the control 2 group and the experimental group (low, medium and high dose groups) all reduced the intoxication rate, delayed the intoxication time of the mice and shortened the sobering-up time compared with the model group. Compared with a control group, the high dose in the experimental group can obviously improve the tolerance capability of the mice to alcohol.
3.2 serum alcohol concentration, liver Alcohol Dehydrogenase (ADH) Activity, and Acetaldehyde Dehydrogenase (ADH) Activity (see Table 2)
TABLE 2 serum alcohol concentration, Alcohol Dehydrogenase (ADH) Activity, acetaldehyde dehydrogenase (ALD) Activity in mice
As can be seen from Table 2, compared with the blank group, the serum ethanol content of the model group mice is obviously increased, the activity of Alcohol Dehydrogenase (ADH) and the activity of acetaldehyde dehydrogenase (ALD) are obviously reduced, the difference is very obvious, and the molding is successful; after the icodextrin-containing carbohydrate electrolyte beverage III is infused, compared with a model group, the serum concentration of a mouse is averagely reduced by 51.7%, the activity of Alcohol Dehydrogenase (ADH) is averagely improved by 45%, and the activity of acetaldehyde dehydrogenase (ALD) is averagely improved by 38.4%, and the anti-alcohol effect is better than that of a control group 1 and a control group 2.
The above embodiments are only used for illustrating the technical solution of the present invention, and not for limiting the same; although the invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof; such modifications and substitutions do not depart from the spirit and scope of the present invention as set forth in the appended claims.
Claims (5)
1. The sugar electrolyte beverage for relieving alcoholism is characterized in that the main raw materials comprise icodextrin, edible glucose and edible salt, and the ratio of the main raw materials is as follows: 4-10g/L of icodextrin, 40-100g/L of edible glucose and 4-9g/L of edible salt; the auxiliary materials are 0.2-1g/L of potassium chloride, a proper amount of citric acid and the balance of drinking water.
2. The sugar electrolyte beverage for alleviating hangover according to claim 1, wherein the ratio of the main raw materials is: 7.5 g/L of icodextrin, 40g/L of edible glucose and 9g/L of edible salt; the auxiliary materials are 0.2g/L of potassium chloride, a proper amount of citric acid and the balance of drinking water.
3. The sugar electrolyte beverage for alleviating hangover according to claim 1, wherein the ratio of the main raw materials is: 4 g/L of icodextrin, 100g/L of edible glucose and 9g/L of edible salt; the auxiliary materials are 1g/L of potassium chloride, a proper amount of citric acid and the balance of drinking water.
4. The sugar electrolyte beverage for alleviating hangover according to claim 1, wherein the ratio of the main raw materials is: 10g/L of icodextrin, 45g/L of edible glucose and 4.5g/L of edible salt; the auxiliary materials are 0.2g/L of potassium chloride, a proper amount of citric acid and the balance of drinking water.
5. A method for producing the sugar electrolyte beverage for hangover alleviation as claimed in any one of claims 1 to 4, comprising the steps of:
(1) preparing according to the mixture ratio of the raw materials: icodextrin, edible glucose, edible salt, potassium chloride, citric acid and drinking water;
(2) adding 60-80 ℃ and 60-85% of full batch volume of drinking water into a container;
(3) then adding icodextrin, edible glucose, edible salt and potassium chloride in sequence, and stirring until the icodextrin, the edible glucose, the edible salt and the potassium chloride are fully dissolved;
(4) adding drinking water to full volume and constant volume, and adjusting pH value to be less than or equal to 7.5 by using citric acid;
(5) UHT sterilizing, packaging, sealing, and packaging.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010604148.1A CN111671025B (en) | 2020-06-29 | 2020-06-29 | Sugar electrolyte beverage for relieving alcoholism and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010604148.1A CN111671025B (en) | 2020-06-29 | 2020-06-29 | Sugar electrolyte beverage for relieving alcoholism and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111671025A CN111671025A (en) | 2020-09-18 |
| CN111671025B true CN111671025B (en) | 2022-04-12 |
Family
ID=72456846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010604148.1A Active CN111671025B (en) | 2020-06-29 | 2020-06-29 | Sugar electrolyte beverage for relieving alcoholism and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111671025B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102234601A (en) * | 2010-04-23 | 2011-11-09 | 中国人民解放军第三军医大学 | Application of oligo-fructose, mannose and derivatives thereof in preparation of functional low-harm wines and anti-inebriation products |
| CN103126026A (en) * | 2011-11-25 | 2013-06-05 | 沈阳科奇医药技术开发有限公司 | Beverage for relieving effect of alcohol and preparation method thereof |
| CN108473528A (en) * | 2015-10-29 | 2018-08-31 | 赛诺米克斯公司 | High intensity sweetner |
-
2020
- 2020-06-29 CN CN202010604148.1A patent/CN111671025B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102234601A (en) * | 2010-04-23 | 2011-11-09 | 中国人民解放军第三军医大学 | Application of oligo-fructose, mannose and derivatives thereof in preparation of functional low-harm wines and anti-inebriation products |
| CN103126026A (en) * | 2011-11-25 | 2013-06-05 | 沈阳科奇医药技术开发有限公司 | Beverage for relieving effect of alcohol and preparation method thereof |
| CN108473528A (en) * | 2015-10-29 | 2018-08-31 | 赛诺米克斯公司 | High intensity sweetner |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111671025A (en) | 2020-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102524883B (en) | Sea cucumber polysaccharide health-care beverage and preparation method thereof | |
| CN106266229B (en) | Enzyme with blood replenishing effect and preparation method thereof | |
| CN101012419A (en) | Application of hyaluronic acid in wine and beer containing hyaluronic acid | |
| CN103054113A (en) | Composite fruit-vegetable juice beverage with blood sugar decreasing effect | |
| CN107149068A (en) | A kind of honey sobering-up beverage and preparation method thereof | |
| CN106721769A (en) | A kind of Chinese yam pear juice composite fermented beverage | |
| WO2022121739A1 (en) | Sweetening liquid capable of preventing and relieving intestinal sugar alcohol intolerance, and preparation method therefor and application thereof | |
| JPH03151854A (en) | Composition for improving intestinal environment | |
| CN111642614A (en) | Anti-alcohol tabletted candy and preparation method thereof | |
| CN106962703A (en) | A kind of red date, fresh ginger air-free soda water and preparation method | |
| CN111671025B (en) | Sugar electrolyte beverage for relieving alcoholism and preparation method thereof | |
| CN112841312A (en) | Collagen milk tea solid beverage and eating method thereof | |
| CN101953487A (en) | Immunity-improving compound fig juice and preparation method thereof | |
| CN112167639A (en) | Composition for bidirectionally regulating morning-onset intestinal fluid balance, preparation method and application thereof | |
| KR101859166B1 (en) | A composition for removing hangover comprising an herb extract including ginseng | |
| CN114451562B (en) | Hovenia dulcis thunb, radix puerariae and corn oligopeptide composition, beverage and preparation method thereof | |
| CN116195695A (en) | Collagen sodium hyaluronate juice beverage and preparation method thereof | |
| KR101870280B1 (en) | A composition for removing hangover comprising an extract of Cinnamomum cassia Presl and cinnamomi petiole | |
| CN107853393B (en) | Composite fruit vinegar milk beverage with intestine moistening and bowel relaxing functions and preparation method and application thereof | |
| CN114938835A (en) | Dihydroquercetin SOD (superoxide dismutase) collagen tripeptide beverage formula | |
| JP2001269135A (en) | Nutritional composition capable of promoting body protein accumulation efficiency | |
| CN111642741A (en) | Production process of intestinal regulator | |
| CN110664984A (en) | Composition with effects of dispelling effects of alcohol and protecting liver and preparation method thereof | |
| CN109674842A (en) | A kind of ion Victoria C Chinese grooseberry composition and preparation method thereof | |
| CN109576100A (en) | A kind of manufacture craft of energy type beer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |